Cellular Reprogramming and Perinatal Therapy

The group's research focuses on pluripotency, translatable iPS cells and cell therapy.

Dr Pascale V Guillot

Research group lead

IRIS profile

Group members

Pascale V Guillot (Head), Kwan-Leong Hau (PhD student), Fabio Tommasini (PhD student), Anna-Maria Ranzoni (PhD student), TBA (Post-Doc), TBA (Post-Doc), 6 MSc students.  

Pluripotency

• Induced Pluripotent Stem (iPS) Cells
• Oct4 and TET enzymes 
• Epigenetic and Signalling Pathways 

Translatable iPS cells

• Chemical Reprogramming to Pluripotency (CiPS cells)
• Small Molecules

Cell Therapy

• Osteogenesis Imperfecta (brittle bone disease)
• Neonatal Brain Damage (Cerebral Palsy)
• Cell Therapy

Location

Institute for Women's Health - Room 205, 86-96 Chenies Mews, London WC1E 6HX

Institute of Child Health - Room 158, 30 Guilford Street, London WC1N 1EH

Further information

• Research students
• Recent findings
• Current projects and external collaborations